REZFORZIN Trademark

Trademark Overview

On Monday, November 9, 2020, a trademark application was filed for REZFORZIN with the United States Patent and Trademark Office. The USPTO has given the REZFORZIN trademark a serial number of 90306711. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 21, 2023. This trademark is owned by Cidara Therapeutics, Inc.. The REZFORZIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations to prevent and treat fungal infections and diseases
rezforzin

General Information

Serial Number90306711
Word MarkREZFORZIN
Filing DateMonday, November 9, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 21, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 23, 2021

Trademark Statements

Goods and ServicesPharmaceutical and biological preparations to prevent and treat fungal infections and diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 7, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCidara Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121
Party NameCidara Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121

Trademark Events

Event DateEvent Description
Monday, August 21, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 21, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 17, 2023SOU EXTENSION 2 GRANTED
Tuesday, January 17, 2023SOU EXTENSION 2 FILED
Tuesday, January 17, 2023SOU TEAS EXTENSION RECEIVED
Friday, July 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 13, 2022SOU EXTENSION 1 GRANTED
Wednesday, July 13, 2022SOU EXTENSION 1 FILED
Wednesday, July 13, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, January 18, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 23, 2021PUBLISHED FOR OPPOSITION
Wednesday, November 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 20, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 19, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 19, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 19, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 19, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 19, 2021NON-FINAL ACTION E-MAILED
Monday, April 19, 2021NON-FINAL ACTION WRITTEN
Friday, April 16, 2021ASSIGNED TO EXAMINER
Thursday, January 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 12, 2020NEW APPLICATION ENTERED

Related Keywords

rezforzin fungal infections diseases treat prevent biological preparations pharmaceutical